Therefore, transcriptional upregulation of TREM2 mRNA expression may be closer coupled to levels of amyloid rather than tau pathology in earlier affected cortical regions; this is despite concurrent elevations in its soluble protein fragment and phosphorylated tau in CSF described in MCI and early AD [27, 51]. This evidence concerns the gene TREM2 and Alzheimer disease.